| Hologic, Inc. (NASDAQ: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world. |
Historically, Hologic developed, manufactured, and marketed products focused on mammography, breast care, and osteoporosis assessment. In 2007, we expanded our focus and now provide a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, mini C-arms for extremity imaging, and molecular diagnostic products including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications. We are proud of this achievement and conscious of the responsibility that our leadership position brings with it. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company. Our core business units are focused on breast health, diagnostics, gynecological surgical, and skeletal health. 
Cytyc and Hologic Together Cytyc and Hologic have combined together under the Hologic name with a shared commitment to enhance women's health through earlier and better detection, improved diagnosis, less invasive treatments and improved patient outcomes. Together, we hold the number one position in nine technology areas serving women's health, including breast cancer diagnosis and treatment, cervical cancer screening, treatment of menorrhagia, prenatal testing, and osteoporosis detection. And together, we can ensure that you will have the very best medical technologies today and long into the future.
|
